Toxic Shock Syndrome Toxin 1 Evaluation and Antibiotic Impact in a Transgenic Model of Staphylococcal Soft Tissue Infection.
Animals
Anti-Bacterial Agents
/ therapeutic use
Bacterial Toxins
/ genetics
Cytokines
Disease Models, Animal
Enterotoxins
/ genetics
Female
HLA-DQ Antigens
/ genetics
Mice, Inbred C57BL
Mice, Transgenic
Shock, Septic
/ drug therapy
Soft Tissue Infections
/ drug therapy
Staphylococcal Infections
/ drug therapy
Staphylococcus aureus
/ drug effects
Superantigens
/ genetics
HLA-DQ8
Staphylococcus aureus
TSST-1
antibiotics
dissemination
nonmenstrual toxic shock syndrome
transgenic mice
Journal
mSphere
ISSN: 2379-5042
Titre abrégé: mSphere
Pays: United States
ID NLM: 101674533
Informations de publication
Date de publication:
09 10 2019
09 10 2019
Historique:
entrez:
11
10
2019
pubmed:
11
10
2019
medline:
27
2
2020
Statut:
epublish
Résumé
Nonmenstrual toxic shock syndrome (nmTSS), linked to TSST-1-producing CC30
Identifiants
pubmed: 31597722
pii: 4/5/e00665-19
doi: 10.1128/mSphere.00665-19
pmc: PMC6796978
pii:
doi:
Substances chimiques
Anti-Bacterial Agents
0
Bacterial Toxins
0
Cytokines
0
Enterotoxins
0
HLA-DQ Antigens
0
HLA-DQ8 antigen
0
Superantigens
0
enterotoxin F, Staphylococcal
0
Types de publication
Evaluation Study
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Medical Research Council
ID : G0800777
Pays : United Kingdom
Informations de copyright
Copyright © 2019 Sharma et al.
Références
J Immunol. 1990 Apr 1;144(7):2473-9
pubmed: 2138648
Infect Immun. 2014 Sep;82(9):3588-98
pubmed: 24914221
Crit Rev Microbiol. 1990;17(4):251-72
pubmed: 2206394
Infect Immun. 2001 Nov;69(11):7169-72
pubmed: 11598096
Clin Microbiol Infect. 2011 Feb;17(2):140-5
pubmed: 20167006
Rev Infect Dis. 1989 Jan-Feb;11 Suppl 1:S254-9
pubmed: 2928644
Crit Rev Microbiol. 1985;12(1):1-44
pubmed: 3160540
Tissue Antigens. 2008 Feb;71(2):135-45
pubmed: 18086265
Infect Genet Evol. 2014 Jan;21:583-92
pubmed: 23541411
J Infect Dis. 2001 Jul 15;184(2):166-73
pubmed: 11424013
Am J Respir Crit Care Med. 2007 Sep 1;176(5):473-82
pubmed: 17575097
Infect Immun. 1990 Dec;58(12):3877-82
pubmed: 2123824
J Exp Med. 1997 Apr 21;185(8):1447-54
pubmed: 9126925
Infect Immun. 2005 Apr;73(4):2452-60
pubmed: 15784591
Eur J Immunol. 1989 Nov;19(11):2171-4
pubmed: 2599004
J Infect. 2015 Sep;71(3):338-46
pubmed: 26028260
J Clin Invest. 1998 Sep 1;102(5):947-57
pubmed: 9727063
Antimicrob Agents Chemother. 2007 Sep;51(9):3374-7
pubmed: 17576837
J Exp Med. 1996 Jun 1;183(6):2635-44
pubmed: 8676084
J Infect Dis. 2009 Aug 15;200(4):555-63
pubmed: 19591574
J Antimicrob Chemother. 2012 Jan;67(1):123-9
pubmed: 21980070
Immunol Rev. 2008 Oct;225:226-43
pubmed: 18837785
MBio. 2012 Mar 20;3(2):null
pubmed: 22434850
Antimicrob Agents Chemother. 2014;58(4):1855-61
pubmed: 24395236
J Infect Dis. 2002 Jun 15;185(12):1754-60
pubmed: 12085321
Emerg Infect Dis. 2018 Feb;24(2):
pubmed: 29350159
Infect Immun. 1989 Jan;57(1):231-4
pubmed: 2909490
HLA. 2017 Jan;89(1):20-28
pubmed: 27863161
Science. 1990 Jun 1;248(4959):1066
pubmed: 2343314
J Immunol. 2005 Nov 15;175(10):6870-7
pubmed: 16272345